Benzalkonium Compounds (Benzalkonium Chloride)
A mixture of alkylbenzyldimethylammonium compounds. It is a bactericidal quaternary ammonium detergent used topically in medicaments, deodorants, mouthwashes, as a surgical antiseptic, and as a as preservative and emulsifier in drugs and cosmetics.
Also Known As:
Benzalkonium Chloride; Benzalkonium; Zephiran; Alkyldimethylbenzylammonium Chloride; Asepsol; BTC-2125; Drapolene; Germex; Osvan; BTC 2125; BTC2125; Chloride, Alkyldimethylbenzylammonium; Chloride, Benzalkonium; Compounds, Benzalkonium
Networked: 210
relevant articles (12 outcomes,
26 trials/studies)
for this Drug,
Comments
Relationship Network
Drug Context: Research Results
- Organic Chemicals: 45
- Amines: 1233
- Quaternary Ammonium Compounds: 957
- Benzylammonium Compounds
- Benzalkonium Compounds: 210
- BGH: 122
- miramistin: 8
- Bradophen: 5
- Timodine: 5
- Cetacaine: 4
- Protectaid: 3
- Fungoid Tincture: 2
- Resiguard: 2
- sterlane: 2
- dexafen: 1
- dimethyldodecylbenzylammonium: 1
- Naphcon A: 1
- pancreatin desogen: 1
- vistagan-liquifilm: 1
- zephiramine: 1
- 1,12-dodecyl-bis(dimethyldodecylammonium bromide)
- 1,4-butyl-bis(dimethyldodecylammonium bromide)
- 4-hydroxy-3-((trimethylammonio)methyl)catechol
- 5-hydroxy-3-((trimethylammonio)methyl)catechol
- benzyldimethyllaurylammonium
- Dequonal
- despa-kowa
- dimethylcocobenzalkonium chloride
- health-dent desensitizer
- hexyl-alpha,omega-bisdodecyldimethylammonium bromide
- Hurriseal
- lubasporin
- migarin
- Movin B
- N,N-dimethyl-N-octadecylbenzylammonium
- N-(3-acetylbenzyl)-N,N-dimethylethylenediammonium dichloride
- nonyl dimethylbenzylammonium
- Panotile
- solamid
- Tegodor 73
- toloconium methylsulfate
- Ultracid F
- Viracea
- Benzalkonium Compounds: 210
- Benzylammonium Compounds
- Quaternary Ammonium Compounds: 957
- Onium Compounds
- Quaternary Ammonium Compounds: 957
- Benzalkonium Compounds: 210
- BGH: 122
- miramistin: 8
- Bradophen: 5
- Timodine: 5
- Cetacaine: 4
- Protectaid: 3
- Fungoid Tincture: 2
- Resiguard: 2
- sterlane: 2
- dexafen: 1
- dimethyldodecylbenzylammonium: 1
- Naphcon A: 1
- pancreatin desogen: 1
- vistagan-liquifilm: 1
- zephiramine: 1
- 1,12-dodecyl-bis(dimethyldodecylammonium bromide)
- 1,4-butyl-bis(dimethyldodecylammonium bromide)
- 4-hydroxy-3-((trimethylammonio)methyl)catechol
- 5-hydroxy-3-((trimethylammonio)methyl)catechol
- benzyldimethyllaurylammonium
- Dequonal
- despa-kowa
- dimethylcocobenzalkonium chloride
- health-dent desensitizer
- hexyl-alpha,omega-bisdodecyldimethylammonium bromide
- Hurriseal
- lubasporin
- migarin
- Movin B
- N,N-dimethyl-N-octadecylbenzylammonium
- N-(3-acetylbenzyl)-N,N-dimethylethylenediammonium dichloride
- nonyl dimethylbenzylammonium
- Panotile
- solamid
- Tegodor 73
- toloconium methylsulfate
- Ultracid F
- Viracea
- Benzalkonium Compounds: 210
- Quaternary Ammonium Compounds: 957
- Amines: 1233
Experts
| 1. | Wallengren, J: 3 articles (12/2002 - 09/2000) |
| 2. | Ito, Yoshimasa: 2 articles (01/2010 - 07/2004) |
| 3. | Kim, Sang-Hoon: 2 articles (12/2007 - 04/2004) |
| 4. | Eleftheriadis, H: 2 articles (11/2007 - 03/2002) |
| 5. | Montgomery, Dawnelle B: 2 articles (01/2007 - 11/2005) |
| 6. | Zucoloto, Sérgio: 2 articles (11/2005 - 02/2003) |
| 7. | Garcia, Sérgio Britto: 2 articles (11/2005 - 02/2003) |
| 8. | Garcia-Godoy, F: 2 articles (01/2001 - 01/2000) |
| 9. | De Goes, M F: 2 articles (01/2001 - 01/2000) |
| 10. | Krecisz, B: 2 articles (01/2000 - 01/2000) |
Related Diseases
Related Drugs and Biologics
Related Therapies and Procedures
| 1. | Drug Therapy (Chemotherapy)
|
| 2. | Denervation
|
| 3. | Injections
|
| 4. | Nebulizers and Vaporizers (Inhaler)
|
| 5. | Transplants (Transplant)
|
TREATMENT OPTIONS
for Infection,
Ranking and Evidence
for Infection,
Ranking and Evidence
CureHunter Patient-Physician Summary Reports collect in one document all the
medications ever reported in the US National Library of Medicine—1949 to the present—to
be effective against your target disease.
Analytic charts allow you and your physicians to see at a glance the
treatment options—including new, promising, off-label and experimental.
- Free Updates for 1 Year
- All 14923 Outcomes
- Top 200 Key Drugs and Biologics
- Top 50 Key Therapies and Procedures
- Detailed History Charts
- Full Research Evidence References
- Sample PDF Report on Psoriasis >>
| Price: | $8.50 USD
& Delivery via
PDF download
updates for 1 year |
Research Interface PRO
- Two-clicks from Disease to Drug to Evidence: Drill down to full abstract
- Enable Experts: Quickly identify key researchers and their publications
- Enable FDA Link Generic: Two-clicks to FDA Products/Patents/Generics
- Enable Export: All outcome statements and scores exportable to Excel/TSV for automated meta-analysis
- Research Network: Explore drug and disease relationships visually
- Enable Mobile Interface: Access from your cellphone, iPhone or PDA
| Price: | $45.00 USD
access via web interface 1 year subscription |